Your session is about to expire
← Back to Search
Digihaler Albuterol Device by TEVA for Childhood Asthma
Study Summary
This trial will test whether an electronic albuterol rescue inhaler can help improve asthma management in a mostly minority and inner-city population of children.
- Childhood Asthma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To whom is this medical experiment available?
"This research project is seeking 40 children with asthma between 8 and 18 years old. To be eligible, prospective participants must have an ICD-9 or 10 code related to asthma, a prescribed albuterol inhaler, access to their own smartphone device, and prior visits to the CHLA allergy clinic."
Are recruitment initiatives for this research currently underway?
"Affirmative. The clinical trial, which was first advertised on June 1st 2021, is in the midst of recruitment according to information provided by clinicaltrials.gov. 40 participants are required from 1 medical centre for this research project."
Are individuals under 25 years of age eligible to join this research study?
"According to the requirements of this clinical trial, participants must be between 8 and 18 years old. 121 trials are currently recruiting minors while 199 trials cater to seniors over 65."
How many individuals have opted to participate in this research endeavor?
"Verified. According to the information housed on clinicaltrials.gov, this trial is actively recruiting members and has been since June 2021 when it was initially posted. The latest update came in March 2022 and 40 participants are needed from just one medical facility."
Share this study with friends
Copy Link
Messenger